Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE EAUL - KERGOURLAY : revenue, balance sheet and financial ratios

PHARMACIE EAUL - KERGOURLAY is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in QUIMPER (29000), this company of category PME shows in 2014 a revenue of 1.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE EAUL - KERGOURLAY (SIREN 798712261)
Indicator 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue N/C N/C N/C N/C N/C N/C N/C N/C 1 310 096 €
Net income 81 915 € 118 637 € 81 163 € 75 409 € 57 414 € 97 975 € 97 999 € 68 105 € -26 834 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C 10 203 €
Net margin N/C N/C N/C N/C N/C N/C N/C N/C -2.0%

Revenue and income statement

Im Jahr 2022 erzielt PHARMACIE EAUL - KERGOURLAY ein positives Nettoergebnis von 82 k€.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

81 915 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 90%. Der Verschuldungsgrad ist hoch: Der Verhandlungsspielraum mit Banken ist reduziert. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 48%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

90.315%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

47.657%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

23.7%

Solvency indicators evolution
PHARMACIE EAUL - KERGOURLAY

Sector positioning

Verschuldungsgrad
90.31 2022
2020
2021
2022
Q1: 24.5
Med: 74.73
Q3: 182.59
Average

Im Jahr 2022 liegt über dem Median der Branche das verschuldungsgrad von PHARMACIE EAUL - KERGOURLAY (90.31). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Eine Reduzierung könnte die finanzielle Stärke verbessern.

Finanzielle Autonomie
47.66% 2022
2020
2021
2022
Q1: 28.53%
Med: 47.06%
Q3: 66.62%
Gut +7 pts over 3 years

Im Jahr 2022 liegt über dem Median der Branche das finanzielle autonomie von PHARMACIE EAUL - KERGOURLAY (47.7%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Diese komfortable Position bietet eine nennenswerte Sicherheitsmarge.

Liquidity ratios

Die Liquiditätsquote beträgt 185.02. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

185.023

Liquidity indicators evolution
PHARMACIE EAUL - KERGOURLAY

Sector positioning

Liquiditätsquote
185.02 2022
2020
2021
2022
Q1: 145.2
Med: 199.49
Q3: 275.01
Average +19 pts over 3 years

Im Jahr 2022 liegt unter dem Median der Branche das liquiditätsquote von PHARMACIE EAUL - KERGOURLAY (185.02). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Eine Verbesserung würde die Wettbewerbsposition stärken.

Working capital requirement (WCR) and payment terms

Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.

Operating WCR (2022) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2022) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2022) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2022) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE EAUL - KERGOURLAY

Positioning of PHARMACIE EAUL - KERGOURLAY in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 215 transactions of similar company sales in 2022, the value of PHARMACIE EAUL - KERGOURLAY is estimated at 963 853 € (range 647 901€ - 1 445 601€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2022
215 transactions
647k€ 963k€ 1445k€
963 853 € Range: 647 901€ - 1 445 601€
NAF 5 année 2022

Valuation method used

Net Income Multiple
81 915 € × 11.8x = 963 854 €
Range: 647 901€ - 1 445 601€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE EAUL - KERGOURLAY with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE EAUL - KERGOURLAY

What is the revenue of PHARMACIE EAUL - KERGOURLAY ?

The revenue of PHARMACIE EAUL - KERGOURLAY in 2014 is 1.3 M€.

Is PHARMACIE EAUL - KERGOURLAY profitable?

Yes, PHARMACIE EAUL - KERGOURLAY generated a net profit of 82 k€ in 2022.

Where is the headquarters of PHARMACIE EAUL - KERGOURLAY ?

The headquarters of PHARMACIE EAUL - KERGOURLAY is located in QUIMPER (29000), in the department Finistere.

Where to find the tax return of PHARMACIE EAUL - KERGOURLAY ?

The tax return of PHARMACIE EAUL - KERGOURLAY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE EAUL - KERGOURLAY operate?

PHARMACIE EAUL - KERGOURLAY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.